1Swash M. ALS 2000: the past points to the future.Amyotrophic lateral sclerosis, 2001; 2 (Sup 1) S3-S9.
2World Federation of Neurology Research Group on Neuromuscular Disease. E1 Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neuro Sci, 1994; 124 (Suppl), 96-107.
4Rowland LP. Research advances in amyotrophic lateral sclerosis (ALS): a personal view. Neurol Neurochir Pol, 2005; 39 (1):3-10.
5Cudkowicz M, Qureshi M, Shefner J. Measures and markers in amyotrophic lateral sclerosis. Neuro Rx,2004; 1 (2): 273-283.
6Eisen A. Recent considerations in the etiopathogenesis of ALS. Suppl Clin Neurophysiol, 2004; 57:187-190.
7Strong MJ, Kesavapany S, Pant HC. The pathobiology of amyotrophic lateral sclerosis: a proteinopathy? J Neuropathol Exp Neurol, 2005; 64 (8): 649-664.
8Van Asseldonk JT, Franssen H, Van den Berg-Vos RM et al. Multifocal motor neuropathy. Lancet Neurol,2005; 4 (5):309-319.
9Nobile-Orazio E, Cappellari A, Priori A. Multifocal motor neuropathy: current concepts and controversies,Muscle Nerve, 2005; 31 (6) : 663-680.
10Schold SC Jr. ALS lessons learned from other neurological diseases. Neuro - oncology. Amyotroph Lateral Scler Other Motor Neuron Disord, 2004; 5 (Suppl 1):34-35.
